PPT-Introduction to Pharmacovigilance

Author : lindy-dunigan | Published Date : 2018-12-10

amp Adverse Drug Reactions Reporting systems Dr Habab Khalid Elkheir BPharm MPharm PhD ISOP ISPE IUATLD SSCP 11282017 Habab khalid Elkheir Objectives of

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Introduction to Pharmacovigilance" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Introduction to Pharmacovigilance: Transcript

amp Adverse Drug Reactions Reporting systems Dr Habab Khalid Elkheir BPharm MPharm PhD ISOP ISPE IUATLD SSCP 11282017 Habab khalid Elkheir Objectives of the workshop. New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepidemiology. Pharmacovigilance. JAMASOFT2017. 2. P. armacovigilance. system collects data . throughout the . lifecycle . of each . medicinal. . product. , MD. Pfizer, India. DISCLAIMER. Overview. Introduction & Terminology. Why Pharmacovigilance?. Pharmacovigilance Practices. : International & Indian. PVPI. Drug Safety Issues in Clinical Trials . Shanthi Pal. Leader, Medicines Safety. Safety . and Vigilance,. WHO, Geneva. What is pharmacovigilance. The science and activities relating to the detection, assessment, understanding and prevention of . Monitoring the safety of medicines. Pharmacovigilance is the science and practices related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Coordinator RSS. N Dellepiane. Shanthi Pal. Leader, Medicines Safety. Safety . and Vigilance,. WHO, Geneva. What is pharmacovigilance. The science and activities relating to the detection, assessment, understanding and prevention of . Prospects and Challenges of Providing Pharmacovigilance Services in Resource Limited Countries Avong YK 1 , Jatau B 1 , Ekong E 1 , Ndembi N 1 , Okuma J 1 , Obieze AI 2 , Osakwe A 2 , Prospects and Challenges of Providing Pharmacovigilance Services in Resource Limited Countries Avong YK 1 , Jatau B 1 , Ekong E 1 , Ndembi N 1 , Okuma J 1 , Obieze AI 2 , Osakwe A 2 , ARVs: Focus on Toxicity Monitoring . and Surveillance of DTG during pregnancy to inform treatment policy . Adele Schwartz Benzaken. . Department . of . STI, . HIV/AIDS . and Viral . Hepatitis. Ministry . 1466 Nikhil GuptaKavita BahmaniAjit Jangra IntroductionPharmacovigilance and drug safety remains As per the World Health Organization (WHO), Pharmacovigilance may be dened ClinicalPractice ISSN No medicine is without . risk and the. . benefits of . a medicine must always be weighed up against its risks. . The . balance of benefits and risks should be effectively considered and must not be left to chance. Authors: . 1. Juliet Jokwiro, . 1. Nicole Chekudambune-Kawaza, . 1. Kenny Sithole, . 1. Bongani Dube, . 2. Charles Sandy, . 2. Manners Ncube, . 2 . Regina Mubau,. 2. Chlorata Gwanzura, . 2. Kwenziweyinkosi Ndlovu, .

Download Document

Here is the link to download the presentation.
"Introduction to Pharmacovigilance"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.